GlaxoSmithKline Pharmaceuticals Ltd. - Research Center

---

(Rs crore)

Profit loss account

	Dec ' 08	Dec ' 07	Dec ' 06	Dec ' 05	Dec ' 04
Income
Operating income	1,676.36	1,578.58	1,541.93	1,474.08	1,367.71
Expenses
Material consumed	650.93	633.21	628.60	637.79	593.71
Manufacturing expenses	71.30	63.87	59.58	45.58	44.40
Personnel expenses	173.05	151.45	153.87	155.66	144.08
Selling expenses	94.58	98.60	103.42	102.19	97.06
Adminstrative expenses	78.06	67.48	100.23	93.10	83.65
Expenses capitalised	-	-	-	-	-
Cost of sales	1,067.92	1,014.60	1,045.70	1,034.33	962.91
Operating profit	608.44	563.98	496.24	439.75	404.80
Other recurring income	104.87	75.46	79.88	55.21	43.04
Adjusted PBDIT	713.31	639.44	576.12	494.96	447.84
Financial expenses	0.53	1.35	1.35	2.36	2.55
Depreciation	16.34	16.16	15.85	15.73	17.47
Other write offs	-	-	-	-	-
Adjusted PBT	696.45	621.93	558.91	476.87	427.82
Tax charges	231.54	211.46	194.23	171.62	152.19
Adjusted PAT	464.91	410.47	364.68	305.25	275.63
Non recurring items	111.16	166.05	174.13	190.99	53.80
Other non cash adjustments	0.50	-38.87	6.70	5.84	3.66
Reported net profit	576.57	537.66	545.51	502.08	333.09
Earnigs before appropriation	1,336.46	1,170.41	986.71	761.83	530.02
Equity dividend	338.81	304.93	262.58	237.17	209.57
Preference dividend	-	-	-	-	-
Dividend tax	57.58	51.82	36.83	33.26	27.39
Retained earnings	940.06	813.65	687.30	491.40	293.06

© Copyright 2009 Rediff.com India Limited. All rights reserved. DisclaimerTerms of ServicePrivacy PolicyFeedback